/주식/PACB
PACB

PACB

Pacific Biosciences of California Inc. Common Stock

$1.160+0.000 (0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.160

고가

$1.160

저가

$1.160

거래량

8.25M

기업 기본 정보

거래 통계

관련 뉴스

PR Newswire

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date

Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq: PACB), a leading...

더 보기
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
GlobeNewswire

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the

더 보기
PacBio to Present at Upcoming Investor Conferences
GlobeNewswire

PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene

MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized

더 보기
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene
Analyst Upgrades

Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.25

Piper Sandler analyst David Westenberg maintains Pacific Biosciences with a Neutral and lowers the price target from $2 to $1.25.

더 보기
Piper Sandler Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.25
Analyst Upgrades

Stephens & Co. Reiterates Overweight on Pacific Biosciences, Maintains $1.8 Price Target

Stephens & Co. analyst Mason Carrico reiterates Pacific Biosciences with a Overweight and maintains $1.8 price target.

더 보기
Stephens & Co. Reiterates Overweight on Pacific Biosciences, Maintains $1.8 Price Target